Company Team Search Site Map Careers Privacy Statement
:: Home
:: About Us
:: R&D
:: Products
:: Services
:: Infrastucture
:: Contact us
Virchow Products
R&D Vision

To ensure continued scientific excellence, we opened, a 25,000-square-foot facility devoted solely to biotechnology research that includes specialized laboratories and state-of-the-science equipment. The experience, diversity and dedication of our Research organization assure that Virchow biotech will continue to play a significant role in discovering new therapies. We encourage you to browse through this research section of our website to learn more about individual research areas and to visit us often for updated information.

News & Events

Virchow Biotech is filing for U.S.Food and Drug administration’s (FDA) approval for its in house developed advanced wound care products.

Virchow Biotech received Drug control’s (DCGI) approval for conducting clinical trials on periogen, an indigenously developed recombinant therapeutic product for periodontal diseases

Virchow Biotech and Ranbaxy signed an MOU to market Virchow’s indigenously developed recombinant therapeutic protein for osteoporosis treatment. We are the first in the world to launch this biogeneric product